News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,396 Results
Type
Article (1931)
Company Profile (2)
Press Release (71463)
Section
Business (21499)
Career Advice (9)
Deals (4564)
Drug Development (8175)
FDA (1810)
Job Trends (806)
News (37092)
Policy (3566)
Tag
2027 BioCapital Standard (1)
Academia (97)
Accelerated approval (5)
ADA (2)
Allergies (21)
Alliances (8179)
ALS (15)
Alzheimer's disease (177)
Antibody-drug conjugate (ADC) (108)
Approvals (1964)
Artificial intelligence (33)
ASCO (37)
Autoimmune disease (32)
Automation (2)
Bankruptcy (8)
Best Places to Work (589)
BIO (7)
Biosimilars (85)
Biotechnology (5)
Bladder cancer (30)
Brain cancer (7)
Breast cancer (62)
Cancer (635)
Cardiovascular disease (26)
Career advice (9)
CAR-T (15)
CDC (1)
Cell therapy (59)
Cervical cancer (5)
Clinical research (7683)
Collaboration (326)
Compensation (25)
Complete response letters (6)
COVID-19 (202)
CRISPR (1)
C-suite (93)
Cystic fibrosis (8)
Data (821)
Depression (15)
Dermatology (11)
Diabetes (40)
Diagnostics (643)
Digital health (7)
Drug discovery (41)
Drug pricing (1)
Duchenne muscular dystrophy (43)
Earnings (8173)
Events (7591)
Executive appointments (73)
FDA (2300)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (149)
Gene editing (7)
Generative AI (1)
Gene therapy (39)
GLP-1 (81)
Government (240)
Grass and pollen (1)
Guidances (39)
Healthcare (1093)
Hematology (14)
HIV (6)
Huntington's disease (3)
IgA nephropathy (22)
Immunology and inflammation (7)
Immuno-oncology (11)
Indications (27)
Infectious disease (228)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (40)
IPO (1643)
Job creations (243)
Job search strategy (9)
JPM (3)
Kidney cancer (1)
Layoffs (6)
Legal (956)
Liver cancer (19)
Longevity (3)
Lung cancer (115)
Lymphoma (54)
Machine learning (1)
Manufacturing (124)
Marketing (1)
MASH (19)
Medical device (1176)
Medtech (1192)
Mergers & acquisitions (3112)
Metabolic disorders (107)
mRNA (7)
Multiple sclerosis (23)
NASH (1)
Neurodegenerative disease (34)
Neuropsychiatric disorders (7)
Neuroscience (329)
NextGen: Class of 2026 (221)
Non-profit (65)
Obesity (36)
Opinion (1)
Ovarian cancer (35)
Pain (18)
Pancreatic cancer (28)
Parkinson's disease (49)
Partnered (3)
Patents (73)
Patient recruitment (71)
Peanut (1)
People (5182)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2076)
Phase 2 (3256)
Phase 3 (2901)
Pipeline (1152)
Policy (1)
Postmarket research (241)
Preclinical (710)
Press Release (2)
Prostate cancer (26)
Radiopharmaceuticals (25)
Rare diseases (84)
Real estate (608)
Regulatory (3024)
Reports (6)
Research institute (97)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (21)
Series A (31)
Series B (23)
Service/supplier (1)
Sickle cell disease (8)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (424)
Stomach cancer (2)
Supply chain (13)
Vaccines (47)
Venture capital (7)
Weight loss (17)
Women's health (7)
Date
Today (12)
Last 7 days (52)
Last 30 days (243)
Last 365 days (2782)
2026 (1478)
2025 (2690)
2024 (3266)
2023 (3825)
2022 (7020)
2021 (6385)
2020 (5877)
2019 (3875)
2018 (3011)
2017 (3568)
2016 (3177)
2015 (4046)
2014 (3031)
2013 (2602)
2012 (2779)
2011 (2914)
2010 (2666)
Location
Africa (88)
Alabama (4)
Arizona (13)
Arkansas (1)
Asia (22260)
Australia (2534)
California (790)
Canada (466)
China (493)
Colorado (5)
Connecticut (23)
Delaware (7)
Europe (13413)
Florida (84)
Georgia (17)
Illinois (41)
India (51)
Indiana (25)
Japan (327)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (122)
Massachusetts (620)
Michigan (9)
Minnesota (40)
Missouri (3)
Nebraska (3)
Nevada (10)
New Hampshire (1)
New Jersey (473)
New York (280)
North Carolina (120)
Northern California (336)
Ohio (6)
Oregon (1)
Pennsylvania (147)
Puerto Rico (1)
Rhode Island (1)
South America (111)
South Carolina (1)
Southern California (386)
Tennessee (1)
Texas (59)
United States (3004)
Utah (29)
Vermont (1)
Virginia (59)
Washington D.C. (3)
Washington State (60)
Wisconsin (7)
73,396 Results for "adalta pty ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy
April 8, 2026
·
5 min read
Press Releases
Elixir MD Launches Australia & New Zealand Subsidiary in Exclusive Partnership with High Tech Medical Pty. Ltd.
August 3, 2025
·
2 min read
Press Releases
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia
April 2, 2025
·
5 min read
Press Releases
Faron Pharmaceuticals Ltd: Registration of Treasury Shares
June 11, 2026
·
2 min read
Press Releases
Faron Pharmaceuticals Ltd: Directorate Appointment
May 5, 2026
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Termination of Liquidity Provision Service
May 6, 2026
·
2 min read
Press Releases
Faron Pharmaceuticals Ltd: Special Rights attached to the First and Second Tranche of Bonds
May 28, 2026
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Results of the Annual General Meeting
May 4, 2026
·
6 min read
Press Releases
FreeMind Investments and Daewoong Pharmaceutical Co., Ltd. Invest in General Proximity
May 4, 2026
·
4 min read
Press Releases
J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment
June 17, 2026
·
1 min read
1 of 7,340
Next
